News
Turning Crisis into Strategy: Contracts, projects and disputes at a global chokepoint
Allen Hicks
Partner Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Allen Hicks is a trusted advisor that helps his clients execute complex strategic transactions, raise and invest capital, and navigate the securities laws. He draws upon a diverse skill set developed through more than two decades of experience with a broad range of companies and industries to provide practical advice and insights for his clients.
Allen has represented public and privately held companies on strategic domestic and cross-border transactions, such as mergers and acquisitions (M&A), stock and asset purchases, divestitures, spinoffs, carve-outs, tender offers and major restructurings and reorganizations. He also has advised public companies on Securities and Exchange Commission (SEC) reporting and disclosure obligations, stock exchange listing requirements, corporate governance, board and shareholder matters, and capital markets offerings of equity and debt.
Over his career, he has represented clients in the U.S. and internationally across various industry sectors, including life sciences and health care, aerospace and defense, diversified industrials, financial services, insurance, hotel and lodging, and technology. His clients range from large, global corporations to middle-market and emerging growth companies and investors to nonprofit organizations.
Before joining the firm, Allen served as Chief Counsel to U.S. Senate Majority Leader William H. Frist. Passionate about the firm's commitment to Pro Bono and Citizenship, Allen also is active in supporting anti-sexual violence organization RAINN and helping find a cure for type 1 diabetes through Breakthrough T1D (formerly JDRF).
Representative experience
Represented Labcorp (NYSE: LH) in over US$5bn of acquisitions, including Genzyme Genetics, Monogram Biosciences, Liposcience, Sequenom, Chiltern, Sciformix, Envigo, and Personal Genome Diagnostics
Represented Labcorp (NYSE: LH) in the US$3bn spinoff of Fortrea, a contract research organization providing clinical trial management and related services to pharmaceutical and biotechnology clients
Represented Labcorp (NYSE: LH) in complex legal entity rationalization, reorganization and rebranding initiatives involving more than 100 legal entities in more than 50 countries
Represented OptumInsight of UnitedHealth Group (NYSE: UNH) in its US$1.3bn acquisition of the health care business of The Advisory Board and OptumRX in its US$300m acquisition of Diplomat Pharmacy
Represented General Electric (NYSE: GE) Capital in the US$9bn sale of its healthcare financial services business to Capital One
Represented REIT American Homes 4 Rent (NYSE: AMH) in more than US$1.3bn of common and preferred stock offerings, including a US$880m IPO
Represented Gilead Sciences (NASDAQ: GILD) in numerous asset acquisitions
Represented a nonprofit U.S. foundation in a reorganization and sale of its holdings in a luxury hotel and residential real estate resort development in Costa Rica
Credentials
Education
- J.D., University of Tennessee, 2000
- M.B.A., University of Tennessee, 2000
- A.B., Stanford University, 1993
Bar admissions and qualifications
- District of Columbia
- Georgia
Memberships
- Member, Business Law Section, American Bar Association